Chronic mexiletine therapy for suppression of ventricular arrhythmias
نویسندگان
چکیده
منابع مشابه
Suppression of chronic ventricular arrhythmias with propranolol.
The antiarrhythmic efficacy of propranolol was evaluated in 32 patients with chronic high frequency ventricular arrhythmias in a placebo-controlled protocol. After a placebo control period, propranolol was begun and the dosage increased sequentially until arrhythmia suppression was achieved, side effects appeared, or a maximum dosage of 960 mg/day was reached. Computerized analysis of ambulator...
متن کاملOral propafenone in the suppression of chronic stable ventricular arrhythmias.
The efficacy of propafenone hydrochloride, a new antiarrhythmic agent, was evaluated in the treatment of chronic stable ventricular arrhythmias. Twenty-five patients who had suffered a myocardial infarction three months or longer before the trial were studied. All exhibited a minimum mean frequency of 30 ventricular ectopic beats per hour over at least two 24-hour Holter monitoring periods with...
متن کاملSuppression of Ventricular Arrhythmias During Placebo and Active Antiarrhythmic Therapy
In the Cardiac Arrhythmia Pilot Study (CAPS), patients early (6-60 days) after acute myocardial infarction (MI) with ventricular premature complexes (VPCs) of over 10 per hour were randomized to receive, unaware, therapy with one of four antiarrhythmic drugs (n =402) or placebo (n = 100). Treatment success was defined as 70% or more decrease in VPC rate and 90% or more decrease in VPC runs. If ...
متن کاملSuppression of Ventricular Arrhythmias by Propafenone,
The responsiveness of ventricular tachycardia (VT) to propafenone, a new antiarrhythmic agent, was evaluated in the conscious dog during acute myocardial infarction (AMI). AMI was produced in the anesthetized closed-chest dogs with an intracoronary catheter system by permanent occlusion in eight dogs and by 2-hour occlusion followed by reperfusion ofthe left anterior descending coronary artery ...
متن کاملMexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
The use of antiarrhythmic drugs to suppress ventricular arrhythmias in pediatric patients with a structurally or hemodynamically abnormal heart appears to improve long-term prognosis. The previously successful use of phenytoin to treat serious ventricular arrhythmias led to the investigation for an alternative antiarrhythmic agent, in the same antiarrhythmic drug class, for those patients who d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cardiology
سال: 1988
ISSN: 0160-9289,1932-8737
DOI: 10.1002/clc.4960110304